MX2023007175A - Agentes para el diagnostico por imagenes predirigidas. - Google Patents
Agentes para el diagnostico por imagenes predirigidas.Info
- Publication number
- MX2023007175A MX2023007175A MX2023007175A MX2023007175A MX2023007175A MX 2023007175 A MX2023007175 A MX 2023007175A MX 2023007175 A MX2023007175 A MX 2023007175A MX 2023007175 A MX2023007175 A MX 2023007175A MX 2023007175 A MX2023007175 A MX 2023007175A
- Authority
- MX
- Mexico
- Prior art keywords
- imaging agents
- pretargeting imaging
- pretargeting
- compounds
- methods
- Prior art date
Links
- 239000012216 imaging agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0495—Pretargeting
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/06—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing halogen atoms, or nitro or nitroso groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención proporciona compuestos novedosos: (ver Fórmulas) métodos para fabricar dichos compuestos, métodos para utilizar dichos compuestos para el diagnóstico por imágenes predirigidas y preparaciones de formulaciones para dicho uso.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063126100P | 2020-12-16 | 2020-12-16 | |
| US202163166484P | 2021-03-26 | 2021-03-26 | |
| PCT/US2021/063552 WO2022132924A1 (en) | 2020-12-16 | 2021-12-15 | Pretargeting imaging agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023007175A true MX2023007175A (es) | 2023-06-30 |
Family
ID=80112113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023007175A MX2023007175A (es) | 2020-12-16 | 2021-12-15 | Agentes para el diagnostico por imagenes predirigidas. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240034722A1 (es) |
| EP (1) | EP4262885A1 (es) |
| JP (1) | JP2023554004A (es) |
| KR (1) | KR20230107651A (es) |
| AU (1) | AU2021400944B2 (es) |
| CA (1) | CA3200750A1 (es) |
| IL (1) | IL303700A (es) |
| MX (1) | MX2023007175A (es) |
| TW (1) | TWI809597B (es) |
| WO (1) | WO2022132924A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017059397A1 (en) | 2015-10-01 | 2017-04-06 | Whitehead Institute For Biomedical Research | Labeling of antibodies |
| KR20220012326A (ko) | 2019-05-24 | 2022-02-03 | 듀크 유니버시티 | 18f-방사선 표지된 생체 분자 |
-
2021
- 2021-12-10 TW TW110146249A patent/TWI809597B/zh active
- 2021-12-15 MX MX2023007175A patent/MX2023007175A/es unknown
- 2021-12-15 KR KR1020237019974A patent/KR20230107651A/ko active Search and Examination
- 2021-12-15 IL IL303700A patent/IL303700A/en unknown
- 2021-12-15 US US18/257,368 patent/US20240034722A1/en active Pending
- 2021-12-15 JP JP2023535896A patent/JP2023554004A/ja active Pending
- 2021-12-15 EP EP21841132.0A patent/EP4262885A1/en active Pending
- 2021-12-15 WO PCT/US2021/063552 patent/WO2022132924A1/en active Application Filing
- 2021-12-15 AU AU2021400944A patent/AU2021400944B2/en active Active
- 2021-12-15 CA CA3200750A patent/CA3200750A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021400944B2 (en) | 2023-12-21 |
| JP2023554004A (ja) | 2023-12-26 |
| IL303700A (en) | 2023-08-01 |
| EP4262885A1 (en) | 2023-10-25 |
| AU2021400944A1 (en) | 2023-06-22 |
| KR20230107651A (ko) | 2023-07-17 |
| CA3200750A1 (en) | 2022-06-23 |
| TWI809597B (zh) | 2023-07-21 |
| US20240034722A1 (en) | 2024-02-01 |
| WO2022132924A1 (en) | 2022-06-23 |
| TW202237579A (zh) | 2022-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019010282A (es) | Formulacion de anticuerpos monoclonales. | |
| NO20030374D0 (no) | Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter | |
| AU2002239344A1 (en) | Pyrazolopyridines | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| MXPA03011197A (es) | Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales. | |
| HK1113970A1 (en) | Formulations for injection of catecholic butanes, including ndga compounds, into animals | |
| PA8583401A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
| IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
| DE60112330D1 (en) | Pyrazolopyridinderivate | |
| MX2021006674A (es) | Composiciones para estabilizar bacterias y usos de las mismas. | |
| MX2022007841A (es) | Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos. | |
| ZA202006071B (en) | Antiproliferation compounds and uses thereof | |
| WO2019087083A3 (en) | Oral delivery of glp-1 peptide analogs | |
| MX2020012281A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. | |
| AU6469401A (en) | Pharmaceutically active compounds and methods of use | |
| MX2023013173A (es) | Degradadores de cinasa 2 dependiente de ciclina (cdk2) y sus usos. | |
| MX2023012848A (es) | Conjugados de anticuerpo-farmaco anti-c-met. | |
| MX2023008634A (es) | Análogos de rapamicina y usos de estos. | |
| MX2023007175A (es) | Agentes para el diagnostico por imagenes predirigidas. | |
| DE60201074D1 (en) | Pyrazolopyridinderivate | |
| JOP20220141A1 (ar) | عوامل التصوير الموجه سلفًا | |
| AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
| MX2023009527A (es) | Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos. | |
| MX2023009604A (es) | Agonista del receptor de somatostatina tipo 5 para el tratamiento de hiperinsulinismo. |